Special Issue "Bioactive Nanoparticles"

Guest Editor
Dr. Bing Yan
St. Jude Faculty, Department of Chemical Biology and Therapeutics, St. Jude Children’s Research Hospital, Room 9064, M/S 1000, 332 North Lauderdale, Memphis, TN 38105, USA
Website: www.stjude.org/Yan
E-Mail:
Interests: nanomedicine; nanotoxicity; cancer therapy; drug discovery; drug resistance; combinatorial chemistry; analytical sciences

Dear Colleagues,

Nanomaterials will potentially play an important role in medicine. However, we need to investigate both medicinal benefits and possible toxicity effects of nanoparticles. Furthermore, the increased manufacturing of nanomaterials and the marketing of nanomaterial-based consumer products all raised health concerns. In recent years, researchers are actively engaged in investigating how nanomaterials transport medicines or genes into targeted cells and how nanomaterials interact with protein signaling pathways, interfere cellular functions and various biological machineries. At the same time, technologies and methods are developed to make more biocompatible nanoparticles for medicinal and imaging application. This special issue includes research reports and review articles reflecting progresses and challenges in the dynamic research area.

Dr. Bing Yan
Guest Editor

Submission

All papers should be submitted to ijms@mdpi.org. To be published continuously until the deadline and papers will be listed together at the special issue website.

Submitted papers should not have been published previously, nor be under consideration for publication elsewhere. All papers are refereed through a peer-review process. A guide for authors is available on the Instructions for Authors page. The International Journal of Molecular Sciences is an international peer-reviewed monthly journal published by Molecular Diversity Preservation International.

Open Access publication fees are 800 CHF per paper. English correction fees and/or formatting fees (250 CHF) will be added in certain cases (1050 CHF per paper for those papers that require extensive additional formatting and/or English corrections).

• Nanoparticle protein interactions
• Nanoparticle cell interaction
• Cancer-targeting nanoparticle
• Nanoparticle for drug delivery
• Nano-imaging agent
• Toxicity of nanoparticle or nanomaterials